Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients

ClinicalTrials.gov ID: NCT00635505

Public ClinicalTrials.gov record NCT00635505. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-Controlled, Parallel, Multi-Center, 12-Week Study to Evaluate the Efficacy and Safety of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Adult and Adolescent Asthmatic Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 12-week clinical study evaluates the safety and efficacy of Albuterol Sulfate HFA Inhalation Aerosol (Albuterol-HFA, or: A004), Armstrong's proposed HFA formulation of metered dose inhaler (MDI) of Albuterol (Treatment T), in comparison with: 1. Placebo control: (HFA propellant only, Treatment P); and 2. Active control: 3M/Key's Proventil-HFA (Treatment R). The treatments will be given as self-administered oral inhalations in adult and adolescent patients with mild-to-moderate asthma, for 12-weeks. Dosing regimen throughout the 12-week study is two actuations four times daily (QID).

Study identification

NCT ID
NCT00635505
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amphastar Pharmaceuticals, Inc.
Industry
Enrollment
300 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2007 (Type not available)
Primary completion
Aug 2008 (Actual)
Completion
Aug 2008 (Actual)
Last update posted
Jul 15, 2013

2007 – 2008

United States locations

U.S. sites
42
U.S. states
18
U.S. cities
37
Facility City State ZIP Site status
Pulmonary Associates of Mobile, PC Mobile Alabama 36608 —
Allergy & Asthma Specialists Medical Group Huntington Beach California 92647 —
Allergy Asthma & Respiratory Care Medical Center Long Beach California 90806 —
Allergy & Asthma Care Center Long Beach California 90808 —
Southern California Research Mission Viejo California 92691 —
CHOC PSF, AMC, Divison AA and I Orange California 92868 —
Clinical Trials of Orange County Orange California 92868 —
Peninsula Research Associates Rolling Hills Estates California 90274 —
Allergy Associates Medical Group San Diego California 92120 —
Allergy & Asthma Associates of Santa Clara Valley Research Centere San Jose California 95117 —
Bensch Research Associates Stockton California 95207 —
Colorado Allergy and Asthma Centers Denver Colorado 80230 —
Colorado Allergy and Asthma Centers Lakewood Colorado 80401 —
Rocky Mountain center for Clinical Research Wheat Ridge Colorado 80033 —
Waterbury Pulmonary Research Waterbury Connecticut 06708 —
Allergy and Asthma Care of Florida Ocala Florida 34471 —
Brandon-Valrico Center for Allergy and Astham Research,LLC Valrico Florida 33594 —
Atlanta Allergy and Asthma Clinic Woodstock Georgia 30188 —
Family Allergy and Asthma Research Institute Louisville Kentucky 40215 —
Northeast Medical Research Group North Dartmouth Massachusetts 02747 —
Park Nicollet Institute Minneapolis Minnesota 55416 —
MEDEX Healthcare Research, Inc. St Louis Missouri 63117 —
The Clinical Research Center, LLC St Louis Missouri 63141 —
Clinical Research Group of Montana Bozeman Montana 59718 —
Montant Medical Research Missoula Montana 59808 —
Asthma and Allergy Center, PC Papillion Nebraska 68046 —
New Horizons Clinical Research Cincinnati Ohio 45242 —
Toledo Center for Clinical Research Sylvania Ohio 43560 —
Integrated Medical Research Ashland Oregon 97520 —
Allergy & Asthma Research Group Eugene Oregon 97504 —
Allergy Asthma and Dermatology Research Lake Oswego Oregon 97035 —
Clinical Research Institute of Southern Oregon Medford Oregon 97504 —
Allergy Associates Research Center Portland Oregon 97213 —
Allergy and Clinical Immunology Associates Pittsburgh Pennsylvania 15241 —
Pharmaceutical Research & Consulting, Inc. Dallas Texas 25231 —
Allergy and Asthma Associates of Houston Houston Texas 77054 —
Clinical Trials of North Houston Houston Texas 77070 —
Kerrville Allergy and Asthma Associates Kerrville Texas 78028 —
Biogenics Research Institute San Antonio Texas 78229 —
Sylvania Research Associates San Antonio Texas 78229 —
Virginia Adult and Pediatric Allergy and Asthma, PC Richmond Virginia 23229 —
Asthma, Inc. Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00635505, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00635505 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →